“Dr. Mel Silverman is a Senior Staff Nephrologist at the Toronto General Hospital, University Health Network, cross appointed at the Mount Sinai and Woman’s College Hospital, and Professor Emeritus of Medicine, University of Toronto.
Dr. Silverman served as Vice President of Research at the Canadian Institute for Advanced Research from 2003-2013. He has played a national leadership role in medical research policy and clinician scientist training, serving at the University of Toronto as founding Director of the MD/PhD Program from 1984 to 2009, as well as the Director of the Institute of Medical Science and Royal College Clinical Investigator Programs.”
Dr. Silverman’s clinical interests include diabetic nephropathy, proteinuria and glomerulonephritis. He has published more than 100 original scientific research papers concerning the molecular physiology of Na+/glucose co-transporter, extracellular matrix – cell signaling in the glomerulus, and the role of RabGTPase 34 and its effector- hmunc 13 in the regulation of the plasminogen/plasmin system and apoptosis.